Company Search:
Advanced Search
Sponsored Links
Dbv Technologies Company Snapshot
Dbv Technologies operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dbv Technologies with three other pharmaceutical manufacturers in Europe: Onxeo SA (2017 sales of 9.51 million Euro [US$11.76 million] ), Amryt Pharma PLC of the United Kingdom (£11.18 million [US$15.97 million] ), and Replek AD Skopje which is based in Macedonia (955.23 million Denar [US$19.18 million] ).

Sales Analysis. Dbv Technologies reported sales of 11.91 million Euro (US$14.74 million) for the year ending December of 2017. This represents an increase of 31.1% versus 2016, when the company's sales were 9.08 million Euro. Sales at Dbv Technologies have increased during each of the previous five years (and since 2012, sales have increased a total of 329%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Dbv Technologies
  Stock Performance Chart for Dbv Technologies
  Stock Data: Recent Stock Performance:
  Current Price (4/13/2018): 38.32
(Figures in Euro)
1 Week -1.0%   13 Weeks 5.0%  
4 Weeks -12.6%   52 Weeks -37.7%  
Dbv Technologies Key Data:
  Ticker: DBV Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 11,909,000
(Year Ending Jan 2018).
Employees: 244
  Currency: Euro Market Cap: 957,459,037
  Fiscal Yr Ends: December Shares Outstanding: 24,985,883
  Share Type: Ordinary Closely Held Shares: 1,003,068
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.